The new technology, aimed at revolutionising unified DNA sequencing by fusing quantum transport with explainable artificial ...

Despite rapid advances in genome and exome sequencing, many individuals with rare diseases remain undiagnosed. In a ...

The development of second tumors is influenced by several factors. These include the type and intensity of treatment received ...

Indore (Madhya Pradesh): A research group at Indian Institute of Technology (IIT), Indore has developed a new technology, ...

MyOme, a leading whole-genome analysis and polygenic risk modeling (PRS) company, announced that it has joined The Partner Collective® by Collective Health®— a digital health partner hub that helps ...

Advances in AI, genomics, and liquid biopsy are reshaping cancer care, but systemic gaps persist in access and funding, ...

Scientists project that by 2026 the results of clinical trials being conducted in 25 countries, including Spain, will be ...

Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced financial results for the first quarter ended March 31, 2025.

The deciding factor is the number of copies of a small DNA sequence within the gray coat gene carried by each horse ...

Have you ever dreamed of writing a heartfelt letter, sealing it in a bottle, and letting the ocean carry it to someone ...